Epivir (Lamivudine) - Adverse Event Reports - Other Serious Reactions

Anaemia (10),  Abortion Spontaneous (8),  Drug Exposure During Pregnancy (8),  Diarrhoea (7),  Immune Reconstitution Syndrome (6),  Intra-Uterine Death (4),  Placental Infarction (4),  Fatigue (4),  Lipodystrophy Acquired (4),  Pregnancy (4)

Adverse event in male receiving Epivir (Lamivudine)

Reported by a physician on 2007-10-23

Patient: male, weighing 89.0 kg (195.8 pounds)

Adverse reactions / side effects: Drug Resistance

Suspect drug(s):
Viramune
    Dosage: 200mg during 14 days, thereafter 400mg
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2007-05-21
    End date: 2007-07-30

Viread
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2007-05-21

Epivir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2007-05-21
    End date: 2007-07-30

Other drugs received by patient: Glucovance; Eusaprim; Eusaprim

Adverse event in 53 year old male receiving Epivir (Lamivudine)

Reported by a physician from United States on 2007-10-12

Patient: 53 year old male

Adverse reactions / side effects: Aspartate Aminotransferase Increased, Alanine Aminotransferase Increased

Suspect drug(s):
Letairis
    Dosage: 5mg per day
    Administration route: Oral
    Start date: 2007-08-09
    End date: 2007-09-12

Epivir
    Dosage: 300mg per day
    Administration route: Oral
    Indication: HIV Infection

Spiriva

Viread
    Dosage: 300mg per day
    Indication: HIV Infection

Sustiva
    Dosage: 600mg per day
    Administration route: Oral
    Indication: HIV Infection

Other drugs received by patient: Lasix; Sildenafil Citrate; Warfarin Sodium; Advair Diskus 100 / 50; Singulair; Metformin HCL; Flomax; Wellbutrin

Adverse event in 44 year old female receiving Epivir (Lamivudine)

Reported by a physician from Japan on 2007-10-11

Patient: 44 year old female

Adverse reactions / side effects: Jaundice, Liver Disorder

Suspect drug(s):
Epivir
    Dosage: 4tab per day
    Administration route: Oral
    Indication: Drug USE FOR Unknown Indication
    Start date: 2007-01-01
    End date: 2007-01-01

Retrovir
    Dosage: 600mg per day
    Administration route: Oral
    Indication: Drug USE FOR Unknown Indication
    Start date: 2007-01-01
    End date: 2007-01-01

Other drugs received by patient: Viracept

Adverse event in 44 year old female receiving Epivir (Lamivudine)

Reported by a physician from Japan on 2007-10-03

Patient: 44 year old female

Adverse reactions / side effects: Jaundice, Liver Disorder

Suspect drug(s):
Epivir
    Administration route: Oral
    Indication: Drug USE FOR Unknown Indication

Retrovir
    Dosage: 600mg per day
    Administration route: Oral
    Indication: Drug USE FOR Unknown Indication

Other drugs received by patient: Viracept

Adverse event in 40 year old female receiving Epivir (Lamivudine)

Reported by a physician from France on 2007-07-30

Patient: 40 year old female

Adverse reactions / side effects: Hepatitis Cholestatic, Portal Hypertension, Hepatic Fibrosis, Lymphopenia, Varices Oesophageal, Lipodystrophy Acquired

Suspect drug(s):
Aprovel Tabs
    Administration route: Oral
    Indication: Hypertension
    End date: 2006-04-18

Videx
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2001-10-01
    End date: 2005-05-16

Epivir
    Indication: HIV Infection
    Start date: 2001-10-01

Viramune
    Indication: HIV Infection
    Start date: 2001-01-01

Viread
    Start date: 2005-03-16

Adverse event in 31 year old female receiving Epivir (Lamivudine)

Reported by a pharmacist from United Kingdom on 2007-07-19

Patient: 31 year old female, weighing 60.5 kg (133.1 pounds)

Adverse reactions / side effects: Umbilical Cord Abnormality, Intra-Uterine Death, Placental Infarction, Abortion Spontaneous

Suspect drug(s):
Epivir
    Dosage: 300mg per day
    Administration route: Oral
    Indication: Retroviral Infection

Didanosine
    Dosage: 250mg per day
    Administration route: Oral
    Indication: Retroviral Infection
    Start date: 2004-09-01

Norvir
    Dosage: 100mg per day
    Administration route: Oral
    Indication: Retroviral Infection

Fuzeon
    Dosage: 180mg per day
    Indication: Retroviral Infection

Reyataz
    Dosage: 300mg per day
    Administration route: Oral
    Indication: Retroviral Infection

Valgancyclovir
    Indication: Cytomegalovirus Infection
    Start date: 2004-09-01

Other drugs received by patient: Cotrim

Adverse event in 27 year old female receiving Epivir (Lamivudine)

Reported by a health professional (non-physician/pharmacist) from Germany on 2007-07-18

Patient: 27 year old female

Adverse reactions / side effects: Cholestasis of Pregnancy, Drug Exposure During Pregnancy, Proteus Infection, Anogenital Warts, Genital Infection

Suspect drug(s):
Combivir
    Dosage: 900mg per day
    Administration route: Oral
    Start date: 2005-02-16

Epivir
    Dosage: 300mg per day
    Administration route: Oral
    Start date: 2004-07-29
    End date: 2005-02-16

Viread
    Dosage: 300mg per day
    Start date: 2004-07-29

Norvir
    Dosage: 400mg per day
    Start date: 2004-07-29
    End date: 2005-02-16

Fuzeon
    Dosage: 180mg per day
    Start date: 2005-03-22
    End date: 2005-03-31

Invirase
    Dosage: 2000mg per day
    Start date: 2004-09-29
    End date: 2005-02-16

Adverse event in 47 year old female receiving Epivir (Lamivudine)

Reported by a consumer/non-health professional from United States on 2007-07-13

Patient: 47 year old female

Adverse reactions / side effects: Abdominal Pain Lower, Fatigue, Anaemia, Pharmaceutical Product Complaint, Eructation, Decreased Appetite

Suspect drug(s):
Epivir
    Dosage: 1tab twice per day
    Administration route: Oral
    Indication: Antiviral Prophylaxis
    Start date: 2007-05-12
    End date: 2007-05-14

Retrovir
    Dosage: 1tab twice per day
    Administration route: Oral
    Indication: Antiviral Prophylaxis
    Start date: 2007-05-12
    End date: 2007-05-14

Combivir
    Dosage: 1tab twice per day
    Administration route: Oral
    Indication: Antiviral Prophylaxis
    Start date: 2007-05-14

Other drugs received by patient: Wellbutrin

Adverse event in 32 year old male receiving Epivir (Lamivudine)

Reported by a consumer/non-health professional from United States on 2007-07-13

Patient: 32 year old male

Adverse reactions / side effects: Multi-Organ Failure, Bone Marrow Failure

Adverse event resulted in: death, hospitalization

Suspect drug(s):
Efavirenz
    Administration route: Oral
    Indication: Acquired Immunodeficiency Syndrome
    Start date: 2006-02-17
    End date: 2006-07-19

Endoxan
    Indication: Plasmablastic Lymphoma
    Start date: 2006-02-01
    End date: 2006-04-11

Retrovir
    Administration route: Oral
    Indication: Acquired Immunodeficiency Syndrome
    Start date: 2006-02-17
    End date: 2006-07-19

Epivir
    Administration route: Oral
    Indication: Acquired Immunodeficiency Syndrome
    Start date: 2006-02-17
    End date: 2006-07-19

Adriamycin PFS
    Indication: Plasmablastic Lymphoma
    Start date: 2006-02-01
    End date: 2006-04-11

Oncovin
    Indication: Plasmablastic Lymphoma
    Start date: 2006-02-01
    End date: 2006-04-11

Predonine
    Administration route: Oral
    Indication: Plasmablastic Lymphoma
    Start date: 2006-02-23
    End date: 2006-03-21

Ganciclovir Sodium
    Indication: Cytomegalovirus Enterocolitis
    Start date: 2006-06-30
    End date: 2006-07-19

Other drugs received by patient: Pentamidine Isethionate

Adverse event in 28 year old female receiving Epivir (Lamivudine)

Reported by a health professional (non-physician/pharmacist) from Botswana on 2007-07-06

Patient: 28 year old female

Adverse reactions / side effects: Abortion Induced

Suspect drug(s):
Viramune
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2004-03-08

Combivir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2004-02-23

Zerit
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2005-03-18

Epivir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2005-03-18

Adverse event in male receiving Epivir (Lamivudine)

Reported by a consumer/non-health professional from United States on 2007-07-02

Patient: male

Adverse reactions / side effects: Eyelid Disorder, Condition Aggravated, Ophthalmoplegia

Suspect drug(s):
Didanosine
    Dosage: 1 caps, qd, oral
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1994-01-01

Epivir
    Dosage: oral
    Administration route: Oral
    Indication: HIV Infection

Crixivan
    Dosage: oral
    Administration route: Oral
    Indication: HIV Infection

Adverse event in 31 year old female receiving Epivir (Lamivudine)

Reported by a pharmacist from United Kingdom on 2007-06-29

Patient: 31 year old female, weighing 60.5 kg (133.1 pounds)

Adverse reactions / side effects: Umbilical Cord Abnormality, Intra-Uterine Death, Placental Infarction, Abortion Spontaneous

Suspect drug(s):
Epivir
    Dosage: 300mg per day
    Administration route: Oral
    Indication: Retroviral Infection

Didanosine
    Dosage: 250mg per day
    Administration route: Oral
    Indication: Retroviral Infection
    Start date: 2004-09-01

Norvir
    Dosage: 100mg per day
    Administration route: Oral
    Indication: Retroviral Infection

Fuzeon
    Dosage: 180mg per day
    Indication: Retroviral Infection

Reyataz
    Dosage: 300mg per day
    Administration route: Oral
    Indication: Retroviral Infection

Valgancyclovir
    Indication: Cytomegalovirus Infection
    Start date: 2004-09-01

Other drugs received by patient: Cotrim

Adverse event in 66 year old male receiving Epivir (Lamivudine)

Reported by a physician from Japan on 2007-06-27

Patient: 66 year old male

Adverse reactions / side effects: Hypoacusis, Pancytopenia, Otitis Media

Adverse event resulted in: hospitalization

Suspect drug(s):
Epivir
    Dosage: 150mg twice per day
    Administration route: Oral
    Indication: Acquired Immunodeficiency Syndrome
    Start date: 2004-12-22
    End date: 2006-05-29

Ziagen
    Dosage: 150mg twice per day
    Administration route: Oral
    Indication: Acquired Immunodeficiency Syndrome
    Start date: 2004-12-31
    End date: 2006-05-29

Retrovir
    Dosage: 400mg per day
    Administration route: Oral
    Indication: Acquired Immunodeficiency Syndrome
    Start date: 2004-12-22
    End date: 2004-12-30

Kaletra
    Dosage: 6cap per day
    Administration route: Oral
    Indication: Acquired Immunodeficiency Syndrome
    Start date: 2004-12-22
    End date: 2006-05-29

Baktar
    Administration route: Oral
    Indication: Pneumocystis Jiroveci Pneumonia
    Start date: 2004-11-18
    End date: 2006-05-29

Other drugs received by patient: Benambax; Funguard; Glyceol; Decadron; Seishoku; Laxoberon; Magnesium Oxide

Adverse event in 28 year old female receiving Epivir (Lamivudine)

Reported by a consumer/non-health professional from France on 2007-06-25

Patient: 28 year old female

Adverse reactions / side effects: Drug Exposure During Pregnancy, Drug Dependence, Treatment Noncompliance

Suspect drug(s):
Epivir
    Administration route: Oral
    Indication: HIV Infection

Retrovir
    Administration route: Oral
    Indication: HIV Infection

Viracept
    Administration route: Oral
    Indication: HIV Infection

Morphine
    Administration route: Oral

Adverse event in 40 year old male receiving Epivir (Lamivudine)

Reported by a individual with unspecified qualification from India on 2007-06-25

Patient: 40 year old male

Adverse reactions / side effects: Pain, Iridocele, Disorder of Globe, Uveitis, Blindness Unilateral, Tuberculosis of Eye, Immune System Disorder, Lung Infiltration, Cough

Suspect drug(s):
Zidovudine
    Dosage: 300 mg
    Indication: HIV Infection

Epivir
    Dosage: 150 mg

Efavirenz
    Dosage: 600 mg

Rifampin
    Dosage: 600 mg

Isoniazid
    Dosage: 300 mg

Pyrazinamide
    Dosage: 1200 mg

Ethambutol Hydrochloride
    Dosage: 800 mg

Adverse event in 44 year old male receiving Epivir (Lamivudine)

Reported by a physician from Japan on 2007-06-21

Patient: 44 year old male

Adverse reactions / side effects: Hepatic Function Abnormal, Malaise, Epigastric Discomfort

Suspect drug(s):
Epivir
    Dosage: 300mg per day
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2006-01-15
    End date: 2006-04-05

Ziagen
    Dosage: 300mg twice per day
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2006-01-15
    End date: 2006-04-05

Other drugs received by patient: Stocrin; Baktar; Zithromac; Truvada; Predonine; Endoxan; Adriamycin PFS; Oncovin

Adverse event in female receiving Epivir (Lamivudine)

Reported by a consumer/non-health professional from United States on 2007-06-14

Patient: female

Adverse reactions / side effects: Electroencephalogram Abnormal, Cerebral Disorder, Drug Exposure During Pregnancy, Rhinitis, Neutropenia, Foetal Growth Retardation, Anaemia Macrocytic

Adverse event resulted in: hospitalization

Suspect drug(s):
Zerit
    Dosage: ongoing gestational weeks 2 through 10
    Indication: HIV Test Positive
    Start date: 1997-05-29
    End date: 1997-07-01

Videx
    Dosage: ongoing at gestational weeks 2 through 10
    Indication: HIV Infection
    Start date: 1997-05-29
    End date: 1997-07-01

Fortovase
    Dosage: initiated at gestational week 29
    Indication: HIV Test Positive
    Start date: 1997-11-12
    End date: 1998-01-19

Retrovir
    Dosage: initiated at gestational week 10
    Indication: HIV Test Positive
    Start date: 1997-07-01
    End date: 1998-01-19

Retrovir
    Dosage: infusion at delivery
    Administration route: Oral
    Indication: Prophylaxis Against HIV Infection
    Start date: 1998-01-01
    End date: 1998-03-01

Crixivan
    Dosage: ongoing gestational week 2 through 10
    Indication: HIV Test Positive
    Start date: 1997-05-29
    End date: 1997-07-01

Epivir
    Dosage: initiated at gestational week 29
    Indication: HIV Test Positive
    Start date: 1997-11-12
    End date: 1998-01-19

Epivir
    Dosage: 6 week course after birth
    Administration route: Oral
    Indication: Prophylaxis Against HIV Infection
    Start date: 1998-01-01
    End date: 1998-03-01

Adverse event in 44 year old male receiving Epivir (Lamivudine)

Reported by a health professional (non-physician/pharmacist) from France on 2007-06-08

Patient: 44 year old male, weighing 50.0 kg (110.0 pounds)

Adverse reactions / side effects: Renal Failure, Melanodermia, Sepsis

Suspect drug(s):
Kivexa
    Dosage: 1tab per day
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2006-11-22

Epivir
    Indication: HIV Infection
    Start date: 2007-03-01
    End date: 2007-04-10

Ziagen
    Indication: HIV Infection
    Start date: 2007-03-01
    End date: 2007-04-10

Other drugs received by patient: Kaletra; Zelitrex; Bactrim; Entecavir; Nexium; Loxen; Topalgic ( France ); Lexomil; Vfend; Vancomycin; Tazocilline

Adverse event in 31 year old female receiving Epivir (Lamivudine)

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2007-06-07

Patient: 31 year old female, weighing 60.5 kg (133.1 pounds)

Adverse reactions / side effects: Umbilical Cord Abnormality, Drug Exposure During Pregnancy, Intra-Uterine Death, Placental Infarction, Abortion Spontaneous

Suspect drug(s):
Didanosine
    Dosage: 250 mg, qd, oral
    Administration route: Oral
    Indication: Retroviral Infection
    Start date: 2004-09-01

Norvir
    Dosage: 100 mg/day, oral
    Administration route: Oral
    Indication: Retroviral Infection

Fuzeon
    Dosage: 90 mg, bid, subcutaneous
    Indication: Retroviral Infection

Valganciclovir HCL
    Indication: Cytomegalovirus Test
    Start date: 2004-09-01

Reyataz(atazanvir)
    Dosage: 300 mg/day, oral
    Administration route: Oral
    Indication: Retroviral Infection

Epivir
    Indication: Retroviral Infection

Cotrim
    Indication: Prophylaxis
    Start date: 2004-01-01

Lamivudine
    Dosage: 300 mg/day, oral
    Administration route: Oral

Adverse event in 37 year old male receiving Epivir (Lamivudine)

Reported by a physician from Japan on 2007-06-05

Patient: 37 year old male

Adverse reactions / side effects: Anaemia

Suspect drug(s):
Epivir
    Dosage: 300mg per day
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2005-10-12

Ziagen
    Dosage: 600mg per day
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2001-10-22
    End date: 2005-06-08

Retrovir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2005-06-13
    End date: 2005-11-10

Lexiva
    Dosage: 700mg twice per day
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2005-02-16
    End date: 2005-06-08

Norvir
    Dosage: 200mg per day
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2005-02-16
    End date: 2005-06-08

Viracept
    Dosage: 1000mg twice per day
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2005-10-12
    End date: 2005-11-10

Other drugs received by patient: Videx EC; Zerit; Stocrin; Reyataz; Diflucan; Loxonin; Urinorm; Furosemide; Aldactone

Adverse event in 31 year old female receiving Epivir (Lamivudine)

Reported by a pharmacist from United Kingdom on 2007-06-04

Patient: 31 year old female, weighing 60.5 kg (133.1 pounds)

Adverse reactions / side effects: Umbilical Cord Abnormality, Intra-Uterine Death, Placental Infarction, Abortion Spontaneous

Suspect drug(s):
Epivir
    Dosage: 300mg per day
    Administration route: Oral
    Indication: Retroviral Infection

Didanosine
    Dosage: 250mg per day
    Administration route: Oral
    Indication: Retroviral Infection
    End date: 2004-01-09

Norvir
    Dosage: 100mg per day
    Administration route: Oral
    Indication: Retroviral Infection

Fuzeon
    Dosage: 180mg per day
    Indication: Retroviral Infection

Reyataz
    Dosage: 300mg per day
    Administration route: Oral
    Indication: Retroviral Infection

Valgancyclovir
    Indication: Cytomegalovirus Infection
    Start date: 2004-09-01

Other drugs received by patient: Cotrimoxazole

Adverse event in 33 year old female receiving Epivir (Lamivudine)

Reported by a consumer/non-health professional from Japan on 2007-05-29

Patient: 33 year old female

Adverse reactions / side effects: Normal Newborn, Musculoskeletal Pain, Anaemia, Blood Triglycerides Increased, Pregnancy, Deep Vein Thrombosis

Suspect drug(s):
Zerit
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1999-02-03

Epivir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1999-02-03

Viracept
    Dosage: viracept (nfv) 2200-2500 mg/day dosed
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1999-02-10

Other drugs received by patient: Retrovir

Adverse event in 47 year old female receiving Epivir (Lamivudine)

Reported by a consumer/non-health professional from United States on 2007-05-23

Patient: 47 year old female

Adverse reactions / side effects: Abdominal Pain Lower, Fatigue, Anaemia, Pharmaceutical Product Complaint, Eructation, Decreased Appetite

Suspect drug(s):
Epivir
    Dosage: 1tab twice per day
    Administration route: Oral
    Indication: Antiviral Prophylaxis
    Start date: 2007-05-12
    End date: 2007-05-14

Retrovir
    Dosage: 1tab twice per day
    Administration route: Oral
    Indication: Antiviral Prophylaxis
    Start date: 2007-05-12
    End date: 2007-05-14

Combivir
    Dosage: 1tab twice per day
    Administration route: Oral
    Indication: Antiviral Prophylaxis
    Start date: 2007-05-14

Other drugs received by patient: Wellbutrin

Adverse event in 38 year old female receiving Epivir (Lamivudine)

Reported by a individual with unspecified qualification from United States on 2007-05-18

Patient: 38 year old female

Adverse reactions / side effects: Stillbirth

Suspect drug(s):
Viread
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2005-12-16

Viread
    Administration route: Oral
    Start date: 2003-05-23
    End date: 2005-11-11

Epivir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2005-12-16

Epivir
    Administration route: Oral
    Start date: 2003-05-23
    End date: 2005-11-11

Zerit
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2005-03-22
    End date: 2005-10-28

Zerit
    Administration route: Oral
    Start date: 2003-05-23
    End date: 2005-03-21

Viramune
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2005-12-16

Viramune
    Administration route: Oral
    Start date: 2005-10-28
    End date: 2005-11-11

Adverse event in 32 year old female receiving Epivir (Lamivudine)

Reported by a individual with unspecified qualification from United States on 2007-05-18

Patient: 32 year old female

Adverse reactions / side effects: Stillbirth

Suspect drug(s):
Viread
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2005-03-14

Epivir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2006-07-06

Zerit
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2006-07-06

Combivir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2005-03-14
    End date: 2006-07-06